Logo
DNA REPAIR DRUGS MARKET ANALYSIS
  2. / Market Insights
  3. Dna Repair Drugs Market Analysis
all report title image

DNA REPAIR DRUGS MARKET ANALYSIS

DNA Repair Drugs Market, By Drug Type (Niraparib, Olaparib, Rucaparib, Talazoparib), By Application (Ovarian Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Peritoneal Cancer, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jul 2024
  • Code : CMI2617
  • Pages :206
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

DNA Repair Drugs Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Clovis Oncology
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline plc (GSK)
  • Novartis AG
  • Roche Holding AG
  • Agios Pharmaceuticals, Inc.
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • BioMarin Pharmaceutical Inc.
  • Takeda Pharmaceutical Company Limited
  • NMS Group

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

DNA Repair Drugs Market to Surpass US$ 16.80 Bn by 2031
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.